From: Dioxin-like activities in serum across European and Inuit populations
 |  | Greenland | Warsaw | Sweden | Kharkiv | All |
---|---|---|---|---|---|---|
AhRag* 1 (RLU/ml serum) | N | 75 | 99 | 78 | 86 | 338 |
 | Median | 24 | 34 | 33 | 26 | 29 |
 | Min | 6.6 | 11 | 8.0 | 8.8 | 6.6 |
 | Max | 257 | 118 | 103 | 56 | 257 |
 | % agonist | 92 | 100 | 95 | 100 | 97 |
AhR-TEQ* 2 (pg/g lipid) | N | 70 | 99 | 76 | 80 | 325 |
 | Median | 197 | 312 | 428 | 337 | 310 |
 | Min | 38 | 72 | 104 | 110 | 38 |
 | Max | 1188 | 1054 | 1261 | 781 | 1261 |
AhRcomp* 3 (RLU/ml serum) | N | 75 | 99 | 78 | 86 | 339 |
 | Median | 8.3 | 6.4 | 6.2 | 5.5 | 6.8 |
 | Min | 3.9 | 3.2 | 1.6 | 1.5 | 1.5 |
 | Max | 16 | 9.1 | 10 | 11 | 16 |
 | % add/syn | 41 | 3.0 | 6.4 | 18 | 16 |
 | %antagonist | 2.7 | 8.0 | 12 | 34 | 14 |
CB-153 (ng/g lipid) | N | 74 | 100 | 98 | 82 | 355 |
 | Median | 220 | 16 | 210 | 47 | 78 |
 | Min | 5.1 | 3.3 | 41 | 5.5 | 3.3 |
 | Max | 5500 | 130 | 1500 | 200 | 5500 |
p,p' -DDE (ng/g lipid) | N | 74 | 100 | 98 | 82 | 355 |
 | Median | 630 | 570 | 240 | 880 | 560 |
 | Min | 66 | 240 | 55 | 320 | 55 |
 | Max | 13000 | 2100 | 2300 | 12000 | 13000 |